Investor Relations
|
Welcome to the Lilly investor relations site. Innovation is our passion -- achieving medical advances for patients who urgently need answers. The measure of our success is the strength of our products and pipeline and our ability to maximize their benefit. Explore this site to find more information about our breakthrough products and financial performance. |
|
Recent Releases
Nov 4, 2009
Oncology On Canvas(SM) Launches 2010 Art Competition for Individuals Touched by Cancer
Nov 2, 2009
Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDA's BYETTA(R) (Exenatide) Injection Update
Events & Presentations
Nov 13, 2009
Credit Suisse Annual Health Care Conference
| NYSE:LLY
$34.50 + 0.07 |
Nov 6, 2009
4:15 PM ET |
